(3-溴甲基苯基)硼酸频哪醇酯 | 214360-74-4

• 物质功能分类: 化学试剂 - 有机试剂 - 磺酸/亚磺酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (3-溴甲基苯基)硼酸频哪醇酯
• 中文别名: 3-溴甲基苯硼酸频哪醇酯；3-溴甲基苯基硼酸频那醇酯；2-(3-溴甲基苯基)-4,4,5,5-四甲基-[1,3,2]二氧杂硼烷
• 英文名称: 2-(3-(bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• 英文别名: (3-bromomethylphenyl)boronic acid pinacol ester；2-[3-(bromomethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
• CAS: 214360-74-4
• 化学式: C₁₃H₁₈BBrO₂
• mdl: MFCD02183481
• 分子量: 297.0
• InChiKey: WUIYGXGXVOHAFW-UHFFFAOYSA-N

物化性质

• 熔点：
  89-91°C
• 沸点：
  360.9±25.0 °C(Predicted)
• 密度：
  1.26±0.1 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  4.58
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.538
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• TSCA：
  No
• 危险品标志：
  Xi
• 海关编码：
  2934999090
• 危险标志：
  GHS07
• 危险性描述：
  H302
• 包装等级：
  III
• 危险类别：
  8
• 危险性防范说明：
  P260,P264,P270,P280,P301+P312+P330,P301+P330+P331,P303+P361+P353,P304+P340+P310,P305+P351+P338+P310,P362+P364,P405,P501
• 危险品运输编号：
  3261
• 储存条件：
  2-8℃

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Bromomethylphenylboronic acid, pinacol ester
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromomethylphenylboronic acid, pinacol ester
CAS number: 214360-74-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H18BBrO2
Molecular weight: 297.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (3-溴甲基苯基)硼酸频哪醇酯 在 四丁基溴化铵 、 palladium diacetate 、 sodium carbonate 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 0.42h， 生成 1-[4-[3-(Morpholin-4-ylmethyl)phenyl]phenyl]ethanone
  参考文献：
  名称：

  Microwave-Mediated Synthesis of an Arylboronate Library

  摘要：

  A series of arylboronates has been synthesized from the reaction of 2-(2-, (3-, or (4-(bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 1{1-3) respectively with a range of N-, S-, and O-nucleophiles, using microwave-mediated chemistry. For the synthesis of N- and S-substituted boronates, a supported base, PS-NMM, was employed, and many reactions were complete within 15 min. With O-nucleophiles, a mixture of tetrabutylammonium bromide, potassium carbonate, and sodium hydroxide was employed. The resulting aminomethyl, mercaptomethyl, or alkoxy-/phenoxymethyl-arylboronates were subjected to microwave-mediated Suzuki Miyaura coupling reactions to afford a range of biaryls in moderate to good yields. The X-ray structures of five boronates were determined.

  DOI：

  10.1021/co100011g
• 作为产物：
  描述：

  3-甲基苯硼酸频呐醇酯 在 N-溴代丁二酰亚胺(NBS) 、 偶氮二异丁腈 作用下， 以 四氯化碳 为溶剂， 反应 1.0h， 生成 (3-溴甲基苯基)硼酸频哪醇酯
  参考文献：
  名称：

  Selective ratiometric detection of H₂O₂ in water and in living cells with boronobenzo[b]quinolizinium derivatives

  摘要：

  用硼酸苯并[b]喹啉衍生物与分析物进行定量反应，可以在水和活细胞中荧光检测H₂O₂。

  DOI：

  10.1039/c4cc02283a

文献信息

• PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
  申请人：MIURA Tomoya

  公开号：US20130085132A1

  公开（公告）日：2013-04-04

  The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use: wherein each symbol is the same as defined in the description.

  本发明提供了一种具有SGLT1抑制活性的下式[Ib]所示的吡唑化合物、或其药物可接受的盐、包含该化合物的药物组合物及其医药用途： 其中每个符号如说明书中所定义。
• Ion Pair-Directed Regiocontrol in Transition-Metal Catalysis: A Meta-Selective C–H Borylation of Aromatic Quaternary Ammonium Salts
  作者：Holly J. Davis、Madalina T. Mihai、Robert J. Phipps

  DOI：10.1021/jacs.6b08164

  日期：2016.10.5

  interactions to direct transition-metal catalysis is a potentially powerful yet relatively underexplored strategy, with most investigations thus far focusing on using hydrogen bonds as the controlling element. We have developed an ion pair-directed approach to controlling regioselectivity in the iridium-catalyzed borylation of two classes of aromatic quaternary ammonium salts, leading to versatile meta-borylated

  使用非共价相互作用直接过渡金属催化是一种潜在的强大但相对未开发的策略，迄今为止大多数研究都集中在使用氢键作为控制元素。我们开发了一种离子对导向的方法来控制铱催化的两类芳族季铵盐的硼化反应中的区域选择性，从而产生多功能的偏硼化产物。通过检查一系列取代的底物，这提供了适合快速多样化的复杂的官能化芳香支架，并更广泛地证明了离子对在过渡金属催化中控制区域化学的可行性。
• Kinase inhibitors
  申请人：Dong Qing

  公开号：US20060084650A1

  公开（公告）日：2006-04-20

  Compounds, pharmaceutical compositions and kits are provided for use with kinases that comprise a compound selected from the group consisting of: wherein the variables are as defined herein.

  提供用于与激酶结合的化合物、药物组合物和试剂盒，所述化合物是从以下组中选择的： 其中变量如本文所述定义。
• Modulators of the nuclear hormone receptor ROR
  申请人：Kamenecka Theodore Mark

  公开号：US09586928B2

  公开（公告）日：2017-03-07

  The invention provides small molecule modulators of retinoic acid receptor-related orphan receptors such as RORα, RORβ, or RORγ, of formula with the variable atoms as defined herein and R1 comprising a hydroxyl- or alkoxyl-substituted fluoroalkyl group. Compounds of the invention can be effective modulators at concentrations ineffective to act on LXR receptors, or on other nuclear receptors, or other biological targets. Methods of modulation the RORs and methods of treating metabolic disorders, immune disorders, cancer, and CNS disorders wherein modulation of an ROR is medically indicated are also provided.

  这项发明提供了类似RORα、RORβ或RORγ的视黄酸受体相关孤儿受体的小分子调节剂，其化学式为 ，其中变量原子如本文所定义，R1包括一个羟基或烷氧基取代的氟烷基团。本发明的化合物可以是有效的调节剂，其浓度对LXR受体或其他核受体或其他生物靶点无效。还提供了调节ROR的方法以及治疗代谢紊乱、免疫紊乱、癌症和中枢神经系统紊乱的方法，其中调节ROR在医学上是指示的。
• [EN] PYRAZOLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF BRUTON'S TYROSINE KINASE<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIMIDINE UTILES COMME INHIBITEURS DE LA TYROSINE KINASE DE BRUTON
  申请人：REDX PHARMA PLC

  公开号：WO2015189620A1

  公开（公告）日：2015-12-17

  This invention relates to compounds of formula (I). The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

  这项发明涉及式(I)的化合物。该发明的化合物是酪氨酸激酶抑制剂。具体来说，该发明的化合物可用作布鲁顿酪氨酸激酶（BTK）的抑制剂。该发明还考虑了利用这些化合物治疗可通过抑制布鲁顿酪氨酸激酶治疗的疾病，例如癌症、淋巴瘤、白血病和免疫性疾病。